AMs asked to shout down diabetes myths for Diabetes Week
Diabetes UK Cymru and Jeff Cuthbert AM are asking AMs to shout down the myths about diabetes in an event at the Welsh Assembly for Diabetes Week (Diabetes UK)
Much to do in tackling this diabetes epidemic
Following the first meeting of the new Cross-Party Group on Diabetes at the National Assembly in March, Dai Williams, national director of Diabetes UK Cymru, explains why it is needed more than ever (Wales Online)
NCD alliance website launched
In conjuction with the World Health Assembly in Geneva, the Non-Communicable Disease (NCD) Alliance has launched a unique global online platform to facilitate the campaign against the growing epidemic of NCDs (International Diabetes Federation)
The effect of healthcare provider education on diabetes management of hospitalised patients
Implementing an educational programme for healthcare providers had significant effects on the lowering of mean BG values and the incidence of hyperglycaemia, but increased the risk of hypoglycaemia (International Journal of Clinical Practice)
Type 2 Diabetes Comorbidities and Treatment Challenges
Many patients with type 2 diabetes have disease-related complications or comorbid conditions, which can hinder disease management. In choosing antihyperglycemic medications, efficacy for improving glycemic control must be balanced against safety and tolerability issues that can adversely affect these complications and comorbidities (Postgraduate Medicine)
Record Number of Medicines Currently in Development to Treat Diabetes
A record 235 new medicines to treat diabetes, one of the fastest-growing diseases in America, are being developed by America’s pharmaceutical research and biotechnology companies, according to a national report (PubMed Diabetes)
Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency
Randomised placebo controlled trial (BMJ)
An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog
Recent guidelines for treatment of type 2 diabetes suggest starting intensive therapy of hyperglycemia at an early stage of diabetes and recommend therapeutic options that provide the possibility of reaching HbA1c goals individually, with a low risk of hypoglycemia or other adverse effects of treatment. The properties of insulin detemir match these requirements (Vascular Health and Risk Management)
EURADIA DIAMAP Road Map reports
Road Map reports are now available for a 1-month consultation period open to the general public (DIAMAP)
Study links viral infection to juvenile diabetes
In a small study of 112 children with juvenile diabetes, Antonio Toniolo of the University of Insubria in Varese, Italy, found that more than 80 percent had evidence of enterovirus infection in their blood (Reuters)
Type 3 Diabetes: Brain Diabetes?
Intensive study is underway in an attempt to better characterize type 3 diabetes and to develop preventative and therapeutic strategies (US Pharmacist)
Endothelial Cell–Derived Endothelin-1 Promotes Cardiac Fibrosis in Diabetic Hearts Through Stimulation of Endothelial-to-Mesenchymal Transition
These results provide new insights suggesting that diabetes mellitus–induced cardiac fibrosis is associated with the emergence of fibroblasts from endothelial cells and that this endothelial-to-mesenchymal transition process is stimulated by ET-1 (Circulation)
TeleHealth Improves Diabetes Self-Management in an Underserved Community: Diabetes TeleCare
Telehealth effectively created access to successfully conduct a one year remote DSME by a nurse CDE and dietitian that improved metabolic control and reduced cardiovascular risk in an ethnically diverse and rural population (Diabetes Care)
Comments about Glycosmedia
If you would like to leave a comment about Glycosmedia that can be published on the website then please use the link to our online form on this page or contact the editor Jim Young by e-mail
Glycosmedia is also available as an App: